# ACCURUN 803 Nucleic Acid Negative Quality Control (HIV, HCV, HBV) (BK040067)

_BBI Diagnostics, A SeraCare Company · Nov 19, 2004 · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/BK040067

## Device Facts

- **Applicant:** BBI Diagnostics, A SeraCare Company
- **Decision Date:** Nov 19, 2004
- **Decision:** SESE

---

**Source:** [https://fda-staging.innolitics.com/device/BK040067](https://fda-staging.innolitics.com/device/BK040067)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com